United States: COVID-19 Designated As Airborne Infectious Disease Under HERO Act - Manatt, Phelps & Phillips LLP

Mondaq

08 Sep 2021 0 shares 1 views

United States: COVID-19 Designated As Airborne Infectious Disease Under HERO Act - Manatt, Phelps & Phillips LLP

Mondaq

Published 08 Sep 2021

On September 6, 2021 (Labor Day), Governor Hochul announced that the commissioner of health has designated COVID-19 a highly contagious communicable disease that presents a serious risk of harm to the public health under New York State's HERO Act.

Full Article

United States: New York Updates Its Model HERO Act Plan Regarding Face Covering Requirements - Littler Mendelson

Mondaq 28 Sep 2021

On September 23, 2021, the New York State Department of Labor updated its requirements for face coverings contained in its model..

United States: NY HERO Act Update: DOL Publishes Revised Model Protocol, Clarifies That Fully-Vaccinated Workforces Need Not Mask - Seyfarth Shaw LLP
Mondaq 28 Sep 2021
United States: New York State Issues Updated Model Workplace Safety Plans And FAQ Guidance Under The HERO Act - Proskauer Rose LLP
Mondaq 27 Sep 2021

United States: COVID-19 Designated As Airborne Infectious Disease Under HERO Act - Manatt, Phelps & Phillips LLP

United States: COVID-19 Designated As Airborne Infectious Disease Under HERO Act - Manatt, Phelps & Phillips LLP

You might like

Related news coverage

United States: New York Updates Its Model HERO Act Plan Regarding Face Covering Requirements - Littler Mendelson

Advertisement